Chemoinformaics analysis of Gingerenone – A
| Molecular Weight | 356.418 | nRot | 9 |
| Heavy Atom Molecular Weight | 332.226 | nRig | 14 |
| Exact Molecular Weight | 356.162 | nRing | 2 |
| Solubility: LogS | -3.45 | nHRing | 0 |
| Solubility: LogP | 2.689 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 12 |
| nHA | 5 | APOL | 55.083 |
| nHD | 2 | BPOL | 28.417 |
| QED | 0.668 |
| Synth | 2.457 |
| Natural Product Likeliness | 1.089 |
| NR-PPAR-gamma | 0.903 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.303 |
| Pgp-sub | 0.008 |
| HIA | 0.012 |
| CACO-2 | -4.758 |
| MDCK | 0.0000207 |
| BBB | 0.085 |
| PPB | 0.979698 |
| VDSS | 0.584 |
| FU | 0.0174207 |
| CYP1A2-inh | 0.874 |
| CYP1A2-sub | 0.95 |
| CYP2c19-inh | 0.889 |
| CYP2c19-sub | 0.122 |
| CYP2c9-inh | 0.862 |
| CYP2c9-sub | 0.934 |
| CYP2d6-inh | 0.909 |
| CYP2d6-sub | 0.936 |
| CYP3a4-inh | 0.867 |
| CYP3a4-sub | 0.304 |
| CL | 15.802 |
| T12 | 0.941 |
| hERG | 0.037 |
| Ames | 0.084 |
| ROA | 0.031 |
| SkinSen | 0.287 |
| Carcinogencity | 0.754 |
| EI | 0.447 |
| Respiratory | 0.131 |
| NR-Aromatase | 0.176 |
| Antiviral | Yes |
| Prediction | 0.654726 |